In conclusion, identification of the extensively characterized AF20 antigen as glycosylated TFR1 explains nearly all the major features of AF20, including its homodimeric structure, cell surface localization, rapid endocytosis of antigen-antibody complex, overexpression in liver and colon cancers, and potential for cancer therapy. Here, TFRC is linked to malignant colon neoplasm.